 |
PDBsum entry 1b1c
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1b1c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Crystal structure of the fmn-binding domain of human cytochrome p450 reductase at 1.93a resolution
|
|
Structure:
|
 |
Protein (NADPH-cytochrome p450 reductase). Chain: a. Fragment: fmn-binding domain. Synonym: p450r-fmn. Ec: 1.6.2.4
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Plasmid: pmp cloned into pet15b
|
|
Resolution:
|
 |
|
1.93Å
|
R-factor:
|
0.197
|
R-free:
|
0.243
|
|
|
Authors:
|
 |
Q.Zhao,S.Modi,G.Smith,M.Paine,P.D.Mcdonagh,C.R.Wolf,D.Tew,L.-Y.Lian, G.C.K.Roberts,H.P.C.Driessen
|
Key ref:
|
 |
Q.Zhao
et al.
(1999).
Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution.
Protein Sci,
8,
298-306.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Nov-98
|
Release date:
|
24-Nov-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P16435
(NCPR_HUMAN) -
NADPH--cytochrome P450 reductase from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
677 a.a.
166 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.6.2.4
- NADPH--hemoprotein reductase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
2 oxidized [cytochrome P450] + NADPH = 2 reduced [cytochrome P450] + NADP+ + H+
|
 |
 |
 |
 |
 |
2
×
oxidized [cytochrome P450]
|
+
|
NADPH
|
=
|
2
×
reduced [cytochrome P450]
|
+
|
NADP(+)
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
FAD; FMN
|
 |
 |
 |
 |
 |
FAD
|
FMN
Bound ligand (Het Group name =
FMN)
corresponds exactly
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Protein Sci
8:298-306
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution.
|
|
Q.Zhao,
S.Modi,
G.Smith,
M.Paine,
P.D.McDonagh,
C.R.Wolf,
D.Tew,
L.Y.Lian,
G.C.Roberts,
H.P.Driessen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of the FMN-binding domain of human NADPH-cytochrome P450
reductase (P450R-FMN), a key component in the cytochrome P450 monooxygenase
system, has been determined to 1.93 A resolution and shown to be very similar
both to the global fold in solution (Barsukov I et al., 1997, J Biomol NMR
10:63-75) and to the corresponding domain in the 2.6 A crystal structure of
intact rat P450R (Wang M et al., 1997, Proc Nat Acad Sci USA 94:8411-8416). The
crystal structure of P450R-FMN reported here confirms the overall similarity of
its alpha-beta-alpha architecture to that of the bacterial flavodoxins, but
reveals differences in the position, number, and length of the helices relative
to the central beta-sheet. The marked similarity between P450R-FMN and
flavodoxins in the interactions between the FMN and the protein, indicate a
striking evolutionary conservation of the FMN binding site. The P450R-FMN
molecule has an unusual surface charge distribution, leading to a very strong
dipole, which may be involved in docking cytochrome P450 into place for electron
transfer near the FMN. Several acidic residues near the FMN are identified by
mutagenesis experiments to be important for electron transfer to P4502D6 and to
cytochrome c, a clear indication of the part of the molecular surface that is
likely to be involved in substrate binding. Somewhat different parts are found
to be involved in binding cytochrome P450 and cytochrome c.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 5.
Fig. 5. GRASP electrostatic potential surface of P450R-FMN seen approx-
imately along the plane of the central b-sheet, perpendicular to the strands,
from b2 toward b5. The protein shows distinct regions of positive and
negative charge giving rise to a dipole roughly in the plane of the sheet
parallel to the strands centred near the centre of gravity pointing from the
flaving ring toward helix 2. Selected positively and negatively charged
residues are indicated in blue and red, respectively.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from the Protein Society:
Protein Sci
(1999,
8,
298-306)
copyright 1999.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
Google scholar
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.C.Marohnic,
S.P.Panda,
K.McCammon,
J.Rueff,
B.S.Masters,
and
M.Kranendonk
(2010).
Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.
|
| |
Drug Metab Dispos,
38,
332-340.
|
 |
|
|
|
|
 |
J.Ellis,
A.Gutierrez,
I.L.Barsukov,
W.C.Huang,
J.G.Grossmann,
and
G.C.Roberts
(2009).
Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering.
|
| |
J Biol Chem,
284,
36628-36637.
|
 |
|
|
|
|
 |
M.Guelker,
L.Stagg,
P.Wittung-Stafshede,
and
Y.Shamoo
(2009).
Pseudosymmetry, high copy number and twinning complicate the structure determination of Desulfovibrio desulfuricans (ATCC 29577) flavodoxin.
|
| |
Acta Crystallogr D Biol Crystallogr,
65,
523-534.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.G.Gherasim,
U.Zaman,
A.Raza,
and
R.Banerjee
(2008).
Impeded electron transfer from a pathogenic FMN domain mutant of methionine synthase reductase and its responsiveness to flavin supplementation.
|
| |
Biochemistry,
47,
12515-12522.
|
 |
|
|
|
|
 |
M.P.Hay,
K.O.Hicks,
K.Pchalek,
H.H.Lee,
A.Blaser,
F.B.Pruijn,
R.F.Anderson,
S.S.Shinde,
W.R.Wilson,
and
W.A.Denny
(2008).
Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.
|
| |
J Med Chem,
51,
6853-6865.
|
 |
|
|
|
|
 |
R.P.Ilagan,
M.Tiso,
D.W.Konas,
C.Hemann,
D.Durra,
R.Hille,
and
D.J.Stuehr
(2008).
Differences in a conformational equilibrium distinguish catalysis by the endothelial and neuronal nitric-oxide synthase flavoproteins.
|
| |
J Biol Chem,
283,
19603-19615.
|
 |
|
|
|
|
 |
M.Fairhead,
S.Giannini,
E.M.Gillam,
and
G.Gilardi
(2005).
Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego.
|
| |
J Biol Inorg Chem,
10,
842-853.
|
 |
|
|
|
|
 |
T.H.Bayburt,
and
S.G.Sligar
(2002).
Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks.
|
| |
Proc Natl Acad Sci U S A,
99,
6725-6730.
|
 |
|
|
|
|
 |
A.Gutierrez,
L.Y.Lian,
C.R.Wolf,
N.S.Scrutton,
and
G.C.Roberts
(2001).
Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
|
| |
Biochemistry,
40,
1964-1975.
|
 |
|
|
|
|
 |
A.W.Munro,
M.A.Noble,
L.Robledo,
S.N.Daff,
and
S.K.Chapman
(2001).
Determination of the redox properties of human NADPH-cytochrome P450 reductase.
|
| |
Biochemistry,
40,
1956-1963.
|
 |
|
|
|
|
 |
A.Gutierrez,
O.Doehr,
M.Paine,
C.R.Wolf,
N.S.Scrutton,
and
G.C.Roberts
(2000).
Trp-676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: properties of the soluble W676H and W676A mutant reductases.
|
| |
Biochemistry,
39,
15990-15999.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |